Welcome to the Hawaii Chapter of the American College of Cardiology


2026 Conference
Click here to learn about our annual Chapter meeting April 25, 2026
Click here to download the flyer

ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings


RSS Latest in Cardiology from ACC.org

  • Novel LA Staging Framework Stratifies NOAF Risk in HCM
    A novel left atrium (LA) staging framework proposed by Jaehyun Lim, MD, PhD, et al., was independently associated with a significant, stepwise increase in risk of new-onset atrial fibrillation (NOAF) in patients with hypertrophic cardiomyopathy (HCM), providing incremental predictive value beyond established atrial fibrillation (AFib) risk models, and may help tailor AFib surveillance strategies for […]
  • AI-Enabled Clinician: Practical Frameworks for Monitoring AI Tools
    In this episode, Dr. Ami Bhatt speaks with Dr. Sneha Jain about evaluating and monitoring artificial intelligence tools for clinical practice.
  • State-of-the-Art Review Proposes Changes to Current CV Subspecialty Training Model
    As cardiovascular subspecialties continue to grow, deficiencies have been exposed in the current training model. A recent State-of-the-Art Review published in JACC: Advances reviews the current training model and how it is being redefined and proposes new training models that can help meet the growing needs of trainees, programs, patients and health care institutions.
  • ALL-RISE: Angiography-Derived Physiology Simplifies PCI Without Compromising Outcomes
    The ALL-RISE (Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment) trial results demonstrated that, among patients with intermediate coronary stenoses undergoing invasive angiography, an angiography-derived fractional flow reserve (FFRangio [Medtronic]) strategy was noninferior to pressure wire–based physiological assessment for death, myocardial infarction, or unplanned clinically indicated revascularization at 1 year.
  • HI-PEITHO and the Evolution of Reperfusion Strategies in Pulmonary Embolism
    Management of intermediate-risk pulmonary embolism (PE) remains one of the most challenging areas in venous thromboembolism care. These patients are hemodynamically stable but have right ventricular (RV) dysfunction and myocardial injury, placing them at increased risk of clinical deterioration.